Pharmabiz19d
US FDA approves Mirum’s Ctexli tablets to treat cerebrotendinous xanthomatosis
Mirum Pharmaceuticals, Inc. announced that the US Food and Drug Administration (FDA) has approved Ctexli (chenodiol) tablets, a bile acid, for the treatment of adults with cerebrotendinous ...
Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
(Nasdaq: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved CTEXLIâ„¢ (chenodiol) tablets, a bile acid, for the treatment of adults with cerebrotendinous xanthomatosis ...